Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion type Assertion NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_head.
- NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_provenance.
- NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion evidence source_evidence_literature NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_provenance.
- NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion SIO_000772 21738581 NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_provenance.
- NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion wasDerivedFrom befree-20150227 NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_provenance.
- NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion wasGeneratedBy ECO_0000203 NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_provenance.